-

COVETRUS, INC. INVESTIGATION CONTINUES: Scott+Scott Attorneys at Law LLP Investigates Clayton, Dubilier & Rice and TPG Capital Buyout of Covetrus, Inc – CVET

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors it is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration. If you are a Covetrus shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether Covetrus’s board of directors failed to maximize the value of Covetrus for the benefit of Covetrus’s shareholders in connection with its announced buyout by funds affiliated with CD&R and TPG, in breach of their fiduciary duties to Covetrus’s shareholders, and whether Covetrus’s shareholders have suffered damages as a result.

On May 25, 2022, Covetrus announced it had reached an agreement to be bought out by funds affiliated with CD&R and TPG for $21.00 per share, in an all-cash transaction valued at approximately $4 billion.

What You Can Do

If you are a Covetrus shareholder, you may have legal claims against Covetrus’s directors. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:CVET

Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Cardinal Infrastructure Group Inc. (NASDAQ: CDNL)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, alerts investors that it is investigating potential violations of U.S. federal securities laws involving Cardinal Infrastructure Group Inc. (NASDAQ: CDNL).CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTIONWhat is Cardinal Infrastructure?Cardinal Infrastructure is a North Carolina-based infrastructure construction company specializing in under...

SIX FLAGS ENTERTAINMENT CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Six Flags Entertainment Corporation’s Directors and Officers for Breach of Fiduciary Duties – FUN

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Six Flags Entertainment Corporation (NYSE: FUN) failed to manage Six Flags in an acceptable manner, breaching their fiduciary duties to Six Flags, and whether Six Flags and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On October 12, 2026, a man died after bein...

BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT:  Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation’s Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 4, 2026, B...
Back to Newsroom